Novel APOB mutation in familial hypobetalipoproteinemia

Affiliations

¹ Lipid and Vascular Risk Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Spain; Faculty of Medicine and Health Sciences. University of Barcelona. Spain; Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBEROBN). Institute of Health Carlos III, ISCIII. Spain.
² Clinical Genetics, Genetic Service. Hospital Universitario Cruces, Basque Country, Spain.
³ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain.
⁴ Lipid and Vascular Risk Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Spain; Faculty of Medicine and Health Sciences. University of Barcelona. Spain; Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBEROBN). Institute of Health Carlos III, ISCIII. Spain. Electronic address: eortega1@clinic.cat.

M Domenech et al. J Clin Lipidol. 2022 Jan-Feb.

. 2022 Jan-Feb;16(1):28-32.

doi: 10.1016/j.jacl.2021.11.003. Epub 2021 Nov 16.

¹ Lipid and Vascular Risk Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Spain; Faculty of Medicine and Health Sciences. University of Barcelona. Spain; Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBEROBN). Institute of Health Carlos III, ISCIII. Spain.
² Clinical Genetics, Genetic Service. Hospital Universitario Cruces, Basque Country, Spain.
³ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain.
⁴ Lipid and Vascular Risk Unit, Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Spain; Faculty of Medicine and Health Sciences. University of Barcelona. Spain; Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBEROBN). Institute of Health Carlos III, ISCIII. Spain. Electronic address: eortega1@clinic.cat.

No abstract available

Keywords: ANGPTL3; APOB mutation; Familial hypobetalipoproteinemia; Fatty liver; Hypocholesterolemia.

MeSH terms